Back to announcement
20260824_SCPI_Ringkasan Risalah//Risalah RUPS_32132244.pdf
RUPS minutes Needs review SCPISource file signed link, expires in 15 minutes
Extracted text 4
Page 1
Go To English Page
Nomor Surat 067/CS-OPI/VIII/2026
Nama Perusahaan PT Organon Pharma Indonesia Tbk
Kode Emiten SCPI
Lampiran 1
Perihal Ringkasan Risalah Rapat Umum Para Pemegang Saham Luar Biasa
Merujuk pada surat Perseroan nomor 059/CS-OPI/VII/2026 tanggal 30 Juli 2026, Perseroan menyampaikan hasil
penyelenggaraan Rapat Umum Pemegang Saham yang dilaksanakan pada tanggal 20 Agustus 2026, sebagai
berikut:
RUPS Luar Biasa
Rapat Umum Pemegang Saham Telah memenuhi kuorum karena dihadiri oleh pemegang saham yang mewakili
3.556.336 saham atau 98,787% dari seluruh saham dengan hak suara yang sah yang telah dikeluarkan oleh
Perseroan, sesuai dengan Anggaran Dasar Perseroan dan Peraturan Perundangan yang berlaku.
Agenda 1 Persetujuan Kuorum Kehadiran Setuju Tidak Setuju Abstain Hasil RUPS
Pengangkatan
Ya 98,787%3.556.33 100% 0 0% 0 0% Setuju
Kembali / Perubahan
6
Susunan Direksi
Hasil Keputusan 1. Menyetujui untuk menerima pengunduran diri YEAP XIN YI dari jabatannya sebagai
Direktur Perseroan, terhitung sejak ditutupnya Rapat ini, serta memberikan pembebasan
dan pelunasan tanggung jawab sepenuhnya (acquit et de charge) atas tindakan pengurusan
yang telah dilakukannya selama masa jabatannya, sepanjang tindakan tersebut tercermin
dalam Laporan Tahunan dan tercatat dalam Laporan Keuangan Perseroan.
2. Menyetujui bahwa selanjutnya susunan anggota Direksi dan Dewan Komisaris Perseroan
menjadi sebagai berikut:
DIREKSI
Presiden Direktur: DANIEL
Direktur: ANDRI SOELASTYO
Direktur: YOHANES INDRAYANA
DEWAN KOMISARIS
Presiden Komisaris: ANDREAS DAUGAARD JORGENSEN
Komisaris: ERWIN AGUNG
Komisaris Independen: EDWARD TANUJAYA
X Susunan Direksi
Prefix Nama Direksi Jabatan Awal Periode Akhir periode Periode Ke Independen
Jabatan Jabatan
Bapak Daniel DIREKTUR 21 Mei 2021 30 Juni 2026 1
UTAMA
Bapak Andri Soelastyo DIREKTUR 21 Mei 2021 30 Juni 2026 1
Bapak Yohanes Indrayana DIREKTUR 10 Juni 2025 30 Juni 2026 1
X Susunan Dewan Komisaris
Prefix Nama Komisaris Jabatan Komisaris Awal Periode Akhir Periode Periode Ke Komisaris
Jabatan Jabatan Independen
Bapak Andreas Daugaard KOMISARIS 21 Mei 2021 30 Juni 2026 1
Jorgensen UTAMA
Bapak Erwin Agung KOMISARIS 21 Mei 2021 30 Juni 2026 1
Bapak Edward KOMISARIS 21 Oktober 2025 30 Juni 2026 1 X
Page 2
Demikian untuk diketahui.
Hormat Kami,
PT Organon Pharma Indonesia Tbk
Arie Noviandari
approver dua
PT Organon Pharma Indonesia Tbk
Sinarmas MSIG Tower, Lantai 37, unit 102 & 106, Jalan Jenderal Sudirman Kaveling
Telepon : 085951102178, Fax : 021-31107009, https://www.organon.com/indonesia/
Nama Pengirim Arie Noviandari
Jabatan approver dua
Tanggal dan Waktu 24-08-2026 13:30
Lampiran 1. OPI - Cover Note.pdf
Dokumen ini merupakan dokumen resmi PT Organon Pharma Indonesia Tbk yang tidak memerlukan tanda tangan
karena dihasilkan secara elektronik oleh sistem pelaporan elektronik. PT Organon Pharma Indonesia Tbk
bertanggung jawab penuh atas informasi yang tertera didalam dokumen ini.
Page 3
Go To Indonesian Page
Letter / Announcement No. 067/CS-OPI/VIII/2026
Issuer Name PT Organon Pharma Indonesia Tbk
Issuer Code SCPI
Attachment 1
Subject Treatise Summary General Meeting of Shareholder's Extra Ordinarynull
Reffering the announcement number 059/CS-OPI/VII/2026 Date 30 July 2026, Listed companies giving report of
general meeting of shareholder’s result on 20 August 2026, are mentioned below :
Extra ordinary general meeting result
Extra ordinary general meeting have fulfill the Kuorum because has been attended by shareholder on behalf of
3.556.336 share of 98,787% from all the shares with company’s valid authority in accordance with company’s
charter and regulations.
Agenda 1 Persetujuan Kuorum Kehadiran Setuju Tidak Setuju Abstain Hasil RUPS
Pengangkatan
Ya 98,787%3.556.33 100% 0 0% 0 0% Setuju
Kembali / Perubahan
6
Susunan Direksi
Hasil Keputusan 1. To approve the resignation of YEAP XIN YI from her position as Director of the Company
effective as of the closing of this Meeting and to grant her full release and discharge (acquit
et de charge) from all liabilities arising from her management actions during her tenure to
the extent that such actions are reflected in the Annual Report and recorded in the Financial
Statements of the Company.
2. To approve that following the above resignation the composition of the Board of Directors
and Board of Commissioners of the Company shall be as follows:
BOARD OF DIRECTORS
President Director: DANIEL
Director: ANDRI SOELASTYO
Director: YOHANES INDRAYANA
BOARD OF COMMISSIONERS
President Commissioner: ANDREAS DAUGAARD JORGENSEN
Commissioner: ERWIN AGUNG
Independent Commissioner: EDWARD TANUJAYA
X Board of Director
Prefix Direction Name Position First Period of Last Period of Period to Independent
Positon Positon
Bapak Daniel PRESIDENT 21 May 2021 30 June 2026 1
DIRECTOR
Bapak Andri Soelastyo DIRECTOR 21 May 2021 30 June 2026 1
Bapak Yohanes Indrayana DIRECTOR 10 June 2025 30 June 2026 1
X Board of commisioner
Prefix Commissioner Commissioner First Period of Last Period of Period to Independent
Name Position Positon Positon
Bapak Andreas Daugaard PRESIDENT 21 May 2021 30 June 2026 1
Jorgensen COMMISSIONER
Bapak Erwin Agung COMMISSIONER 21 May 2021 30 June 2026 1
Bapak Edward COMMISSIONER 21 October 2025 30 June 2026 1 X
Page 4
Thus to be informed accordingly.
Respectfully,
PT Organon Pharma Indonesia Tbk
Arie Noviandari
approver dua
PT Organon Pharma Indonesia Tbk
Sinarmas MSIG Tower, Lantai 37, unit 102 & 106, Jalan Jenderal Sudirman Kaveling
Phone : 085951102178, Fax : 021-31107009, https://www.organon.com/indonesia/
Sender Name Arie Noviandari
Function approver dua
Date and Time 24-08-2026 13:30
Attachment 1. OPI - Cover Note.pdf
This is an official document of PT Organon Pharma Indonesia Tbk that does not require a signature as it was
generated electronically by the electronic reporting system. PT Organon Pharma Indonesia Tbk is fully responsible
for the information contained within this document.
Names mentioned 10 people and organisations named in the text · linked when the evidence is strong
unresolved
person
DANIEL
· Presiden Direktur
p.1 ×5
unresolved
person
ANDRI SOELASTYO
· Direktur
p.1 ×3
unresolved
person
YOHANES INDRAYANA
· Direktur
p.1 ×3
unresolved
person
ANDREAS DAUGAARD JORGENSEN
· Presiden Komisaris
p.1 ×5
unresolved
person
ERWIN AGUNG
· Komisaris
p.1 ×3
unresolved
person
Edward
· KOMISARIS
p.1
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
Rule parser
Needs review
confidence 0.444
210 ms
12 Sep 2026 21:41
no vote table found
Raw output
{'agenda': [],
'is_electronic': True,
'meeting_type': 'EGM',
'pct_present': '98.787',
'shares_present': '3556336'}